发明名称 |
USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY |
摘要 |
The present invention provides methods of lowering body weight by administering an FGF-21 compound in combination with a GLP-1 compound. In addition, the present invention also provides methods to treat obesity by administering an FGF-21 compound in combination with a GLP-1 compound. The present invention also discloses combinations useful in the methods of the present invention. |
申请公布号 |
EP2185178(A2) |
申请公布日期 |
2010.05.19 |
申请号 |
EP20080796800 |
申请日期 |
2008.07.30 |
申请人 |
ELI LILLY AND COMPANY |
发明人 |
COSKUN, TAMER;GLAESNER, WOLFGANG |
分类号 |
A61K38/18;A61K38/26;A61P3/04 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|